Skip to main content
. Author manuscript; available in PMC: 2010 Jan 1.
Published in final edited form as: Schizophr Res. 2008 Sep 10;107(1):69–75. doi: 10.1016/j.schres.2008.07.014

Table 2.

Standardized Scores for Psychopathology and Neurocognition

SCZ (n=72) PMD (n=25) CON (n=72) ANOVA F Statistic(df1, df2)a,b Homogeneity F Statistic Effect Size (ηp2)c
Psychopathology
 Positive Symptoms .318 .082 −.769 81.1 (2,48)***d 15.6*** .17/.02
 Negative Symptoms .331 −.081 −.777 55.5(2,47)*** e 6.6** .26/.08
 Disorganized Symptoms .226 .230 −.531 7.3(2,107)***d 2.6 .12/.00
Neurocognition
 Crystallized IQ −.467 .094 .483 23.4(2,166)***f 0.7 .22/.08
 Working Memory −.510 −.290 .399 31.0(2,166)***g 0.8 .27/.02
 Episodic Memory −.625 −.498 .756 78.8(2,166)***g 0.6 .49/.01
 Executive Functioning −.484 −.342 .401 32.3(2, 66)***g 3.5* .27/.01
*

p<.05,

**

p<.01,

***

p<.001

Note. CON: n=13 for psychopathology and n=72 for neurocognition

a

Pairwise Comparisons (Bonferroni): p<.05

b

Welch ANOVA with Tamhane Pairwise Correction for Unequal Variances used when homogeneity non-significant.

c

First effect size reports difference between all three groups/second effect size reports contrast for SCZ vs. PMD.

d

SCZ, PMD>CON

e

SCZ>PMD>CON

f

SCZ<PMD, CON

g

SCZ, PMD<CON

HHS Vulnerability Disclosure